Vascular System: Role of Nitric Oxide in Cardiovascular Diseases
Level 5 - mechanism / opinion, no new human data
Narrative review of physiological and pathological mechanisms with no original human empirical data or systematic search.
OpenAlex W2004742560 · doi:10.1111/j.1751-7176.2008.06632.x
What was done
This paper provides a historical and physiological overview of nitric oxide (NO) as a signaling molecule in the cardiovascular system and other organ systems, summarizing its role in physiological regulation and various inflammatory and degenerative pathologies.
What was found
The abstract provides no empirical data or quantitative effect sizes. It describes NO as a mediator of smooth muscle relaxation, inhibition of platelet and leukocyte aggregation, suppression of vascular smooth muscle proliferation, neurotransmission, and immune defense. It notes that brief, low nanomolar production of NO operates via cyclic guanosine monophosphate (cGMP)-dependent signaling, whereas sustained, higher-concentration production acts through direct protein interactions (or reactive nitrogen species) independent of the cGMP pathway and is implicated in inflammatory diseases such as arthritis, myocarditis, colitis, nephritis, cancer, and neurodegenerative disorders.
Why it matters
It outlines the distinction between physiological cGMP-dependent signaling at low concentrations and pathological cGMP-independent actions at high concentrations, providing context for cardiovascular and inflammatory therapeutics.
Limits
The abstract describes a broad narrative overview without systematic search criteria, quality appraisal, or primary experimental data. No patient outcomes, sample sizes, or quantitative risk estimates are reported.
Cited by
- supports A Nobel Prize was awarded for the discovery of nitric oxide and its biological role.